메뉴 건너뛰기




Volumn 18, Issue 1, 2018, Pages

A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema

Author keywords

Anti VEGF; Dexamethasone implant; Diabetic macular edema; Meta analysis; Ozurdex

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; BEVACIZUMAB; DEXAMETHASONE; GLUCOCORTICOID; RANIBIZUMAB; VASCULOTROPIN A;

EID: 85047308545     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/s12886-018-0779-1     Document Type: Article
Times cited : (98)

References (43)
  • 1
    • 0021263352 scopus 로고
    • Macular edema. A complication of diabetic retinopathy
    • 6379946
    • Ferris FL 3rd, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol. 1984;28 Suppl:452-61.
    • (1984) Surv Ophthalmol , vol.28 , pp. 452-461
    • Ferris, F.L.1    Patz, A.2
  • 4
    • 0021748399 scopus 로고
    • The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema
    • 6521986
    • Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91:1464-74.
    • (1984) Ophthalmology , vol.91 , pp. 1464-1474
    • Klein, R.1    Klein, B.E.2    Moss, S.E.3    Davis, M.D.4    DeMets, D.L.5
  • 14
    • 84861327424 scopus 로고    scopus 로고
    • Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
    • 22569393 3361827
    • Sharma A, Madhusudhan RJ, Nadahalli V, Damgude SA, Sundaramoorthy SK. Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report. Indian J Ophthalmol. 2012;60:234-5.
    • (2012) Indian J Ophthalmol , vol.60 , pp. 234-235
    • Sharma, A.1    Madhusudhan, R.J.2    Nadahalli, V.3    Damgude, S.A.4    Sundaramoorthy, S.K.5
  • 15
    • 85047776758 scopus 로고    scopus 로고
    • Longterm treatment of diabetic macular edema with dexamethasone im plant after unsatisfactory response to anti- VEGF therapy
    • Garweg JG, Zandi S. Longterm treatment of diabetic macular edema with dexamethasone Im plant after unsatisfactory response to anti- VEGF therapy. Investig Ophthalmol Vis Sci. 2015;56:217.
    • (2015) Investig Ophthalmol Vis Sci , vol.56 , pp. 217
    • Garweg, J.G.1    Zandi, S.2
  • 17
    • 85047737045 scopus 로고    scopus 로고
    • Reduced efficacy of intravitreal dexamethasone implant in diabetic macular edema with subfoveal cystoid spaces
    • Sun HJ, Lee SJ. Reduced efficacy of intravitreal dexamethasone implant in diabetic macular edema with subfoveal cystoid spaces. Investig Ophthalmol Vis Sci. 2016;57:3249.
    • (2016) Investig Ophthalmol Vis Sci , vol.57 , pp. 3249
    • Sun, H.J.1    Lee, S.J.2
  • 19
    • 84945912720 scopus 로고    scopus 로고
    • Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
    • 26519345
    • Augustin AJ, Kuppermann BD, Lanzetta P, Loewenstein A, Li X-Y, Cui H, Hashad Y, Whitcup SM. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study. BMC Ophthalmol. 2015;15. PMID: 26519345. https://doi.org/10.1186/s12886-015-0148-2.
    • (2015) BMC Ophthalmol , pp. 15
    • Augustin, A.J.1    Kuppermann, B.D.2    Lanzetta, P.3    Loewenstein, A.4    Li, X.-Y.5    Cui, H.6    Hashad, Y.7    Whitcup, S.M.8
  • 20
    • 85047740894 scopus 로고    scopus 로고
    • Intravitreal dexamethasone implant (Ozurdex) as primary treatment for diabetic macular edema
    • Cui QN, Stewart JM. Intravitreal dexamethasone implant (Ozurdex) as primary treatment for diabetic macular edema. Investig Ophthalmol Vis Sci. 2014;55:1780.
    • (2014) Investig Ophthalmol Vis Sci , vol.55 , pp. 1780
    • Cui, Q.N.1    Stewart, J.M.2
  • 21
    • 68049122102 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    • The PG 19621072 2707599
    • Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
    • (2009) PLoS Med , vol.6 , pp. e1000097
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4
  • 24
    • 84973884837 scopus 로고    scopus 로고
    • Prospective randomized subject-masked study of intravitreal bevacizumab monotherapy versus dexamethasone implant monotherapy in the treatment of persistent diabetic macular edema
    • 27124881
    • Shah SU, Harless A, Bleau L, Maturi RK. Prospective randomized subject-masked study of intravitreal bevacizumab monotherapy versus dexamethasone implant monotherapy in the treatment of persistent diabetic macular edema. Retina. 2016;36:1986-96.
    • (2016) Retina , vol.36 , pp. 1986-1996
    • Shah, S.U.1    Harless, A.2    Bleau, L.3    Maturi, R.K.4
  • 25
    • 84992386850 scopus 로고    scopus 로고
    • Vision-related quality of life outcomes in the BEVORDEX study: A clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema
    • 27768792
    • Aroney C, Fraser-Bell S, Lamoureux EL, Gillies MC, Lim LL, Fenwick EK. Vision-related quality of life outcomes in the BEVORDEX study: a clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci. 2016;57:5541-6.
    • (2016) Invest Ophthalmol Vis Sci , vol.57 , pp. 5541-5546
    • Aroney, C.1    Fraser-Bell, S.2    Lamoureux, E.L.3    Gillies, M.C.4    Lim, L.L.5    Fenwick, E.K.6
  • 29
    • 79960190061 scopus 로고    scopus 로고
    • Inflammation in diabetic retinopathy
    • 21635964 3433044
    • Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30:343-58.
    • (2011) Prog Retin Eye Res , vol.30 , pp. 343-358
    • Tang, J.1    Kern, T.S.2
  • 30
    • 42449135678 scopus 로고    scopus 로고
    • Immunological mechanisms in the pathogenesis of diabetic retinopathy
    • 18340447
    • Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30:65-84.
    • (2008) Semin Immunopathol , vol.30 , pp. 65-84
    • Adamis, A.P.1    Berman, A.J.2
  • 31
    • 84871311849 scopus 로고    scopus 로고
    • Cytokine concentration in aqueous humor of eyes with diabetic macular edema
    • 22617833
    • Jonas JB, Jonas RA, Neumaier M, Findeisen P. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina. 2012;32:2150-7.
    • (2012) Retina , vol.32 , pp. 2150-2157
    • Jonas, J.B.1    Jonas, R.A.2    Neumaier, M.3    Findeisen, P.4
  • 32
    • 2442547705 scopus 로고    scopus 로고
    • Corticosteroids in posterior segment disease: An update on new delivery systems and new indications
    • 15118508
    • Ciulla TA, Walker JD, Fong DS, Criswell MH. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications. Curr Opin Ophthalmol. 2004;15:211-20.
    • (2004) Curr Opin Ophthalmol , vol.15 , pp. 211-220
    • Ciulla, T.A.1    Walker, J.D.2    Fong, D.S.3    Criswell, M.H.4
  • 35
    • 84938810401 scopus 로고    scopus 로고
    • A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-vegf injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy
    • 25829346
    • Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW. A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-vegf injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy. Retina. 2015;35:1604-14.
    • (2015) Retina , vol.35 , pp. 1604-1614
    • Maturi, R.K.1    Bleau, L.2    Saunders, J.3    Mubasher, M.4    Stewart, M.W.5
  • 36
    • 85021119472 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor for diabetic macular oedema
    • 25342124
    • Virgili G, Parravano M, Menchini F, Evans JR. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev 2014:Cd007419. PMID:25342124. https://doi.org/10.1002/14651858.CD007419.pub4.
    • (2014) Cochrane Database Syst Rev , pp. Cd007419
    • Virgili, G.1    Parravano, M.2    Menchini, F.3    Evans, J.R.4
  • 37
    • 84958568980 scopus 로고    scopus 로고
    • Systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: A systematic review and meta-analysis
    • 26513684
    • Avery RL, Gordon GM. Systemic safety of prolonged monthly anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis. JAMA Ophthalmol. 2016;134:21-9.
    • (2016) JAMA Ophthalmol , vol.134 , pp. 21-29
    • Avery, R.L.1    Gordon, G.M.2
  • 38
    • 70350575734 scopus 로고    scopus 로고
    • Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies
    • 19712924
    • Csaky K, Do DV. Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies. Am J Ophthalmol. 2009;148:647-56.
    • (2009) Am J Ophthalmol , vol.148 , pp. 647-656
    • Csaky, K.1    Do, D.V.2
  • 39
    • 80052445162 scopus 로고    scopus 로고
    • Economic considerations of macular edema therapies
    • 21507488 3483086
    • Smiddy WE. Economic considerations of macular edema therapies. Ophthalmology. 2011;118:1827-33.
    • (2011) Ophthalmology , vol.118 , pp. 1827-1833
    • Smiddy, W.E.1
  • 40
    • 84988699023 scopus 로고    scopus 로고
    • Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
    • 27621587 5010173
    • Thomas BJ, Yonekawa Y, Wolfe JD, Hassan TS. Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema. Clin Ophthalmol. 2016;10:1679-84.
    • (2016) Clin Ophthalmol , vol.10 , pp. 1679-1684
    • Thomas, B.J.1    Yonekawa, Y.2    Wolfe, J.D.3    Hassan, T.S.4
  • 41
    • 84897576584 scopus 로고    scopus 로고
    • Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant
    • 23975006
    • Lazic R, Lukic M, Boras I, Draca N, Vlasic M, Gabric N, Tomic Z. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Retina. 2014;34:719-24.
    • (2014) Retina , vol.34 , pp. 719-724
    • Lazic, R.1    Lukic, M.2    Boras, I.3    Draca, N.4    Vlasic, M.5    Gabric, N.6    Tomic, Z.7
  • 43


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.